24 results for “integration”
Releaf is one of the first medical cannabis clinics to integrate with the NHS’ Spine service, the digital backbone of healthcare across the UK. Could this be a turning point in how clinicians view and engage with cannabis-based medicines?
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
It is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university.
Chancellor Rachel Reeve’s recent budget announcement is yet to be fully digested, and the implications for UK businesses and the wider public are still being analysed. However, one thing remains […]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in […]
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development […]
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
Spain’s Council of Ministers has approved a Royal Decree regulating the medicinal use of cannabis preparations in hospital settings.
Just months ago, France’s long battle to establish a permanent generalised medical cannabis framework was on the brink of failure. Despite other major European countries looking to France’s 2019 pilot […]
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing […]
A new pilot project has found that medical cannabis may help with recovery from substance use challenges.
Cannabis clinics can play a crucial role in changing this landscape by setting high professional standards and ensuring patients receive the same level of care as with any other medical treatment.
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes […]
In a report from November 2023, France’s Directorate General of Health (DGS) recommended the roll out of a temporary regulatory framework.
Cannaray Limited, its medical cannabis subsidiary Therismos, and Canadian ‘aquaponics’ cannabis cultivator Aqualitas are set to merge to create a new international vertically integrated cannabis company. Officially launching at Cannabis […]
Script Assist’s medical cannabis technology platform will now be available on a software as a service (SaaS) basis for the first time.
The first patient to receive medical cannabis flower through the NHS has shared how it helped him manage debilitating side-effects of cancer treatment.
Adam Kavalier PhD, scientific director of Anthera Pharmaceuticals, explores what we know about medical cannabis in the treatment of PTSD.
Cristelle Santos, consultant toxicologist at Broughton Group, shares her experiences as a toxicologist in the CBD sector.
Phytovista Laboratories, a leading provider of cannabinoid and medicinal product analytical testing services, proudly announces its instrumental role in helping a renowned CBD supplement client become the first product with […]
A sixth pilot for the sale of adult-use cannabis has been approved in Basel-Landschaft.
